Skip to main content
Julie Paik, MD, Rheumatology, Baltimore, MD, Johns Hopkins Hospital

JulieJisunPaikMDMHS

Rheumatology Baltimore, MD

Myositis, Scleroderma & Related

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Paik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Paik's full profile

Already have an account?

Summary

  • Dr. Julie Paik is a rheumatologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. She received her medical degree from George Washington University School of Medicine and has been in practice 11 years. She also speaks multiple languages, including Korean. She specializes in myositis and scleroderma & related.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2010 - 2013
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 2006 - 2009
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - Present
  • FL State Medical License
    FL State Medical License 2020 - Present
  • MD State Medical License
    MD State Medical License 2013 - 2025
  • VA State Medical License
    VA State Medical License 2023 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Most RMD Patients Retain Antibodies 6 Months After COVID-19 Vaccination
    Most RMD Patients Retain Antibodies 6 Months After COVID-19 VaccinationFebruary 14th, 2022
  • COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among Immunocompromised
    COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among ImmunocompromisedNovember 22nd, 2021
  • Researchers Describe First Reports of Breakthrough COVID Infections, Booster Shots in Rheumatology Patients
    Researchers Describe First Reports of Breakthrough COVID Infections, Booster Shots in Rheumatology PatientsSeptember 13th, 2021
  • Join now to see all

Other Languages

  • Korean

Hospital Affiliations